The number of people diagnosed with tuberculosis (TB) worldwide surged in 2024, surpassing the previous record set in 2023, according to the World Health Organization (WHO). This trend signals both progress and ongoing challenges in global TB control efforts.
Rising Diagnoses Reflect Improved Detection
In 2024, approximately 8.3 million individuals were newly diagnosed with TB globally. The WHO emphasized that this figure represents about 78% of the estimated total number of people who fell ill with the disease, as not all cases are formally diagnosed. Health experts interpret this increase as evidence that TB screening and treatment services are improving after disruptions caused by the COVID-19 pandemic.
Deaths from TB Show Modest Decline
Despite the rise in reported cases, TB-related deaths decreased slightly in 2024. Globally, 1.23 million people died from the disease last year, down from 1.25 million in 2023. This decline highlights the impact of ongoing treatment programs, even as challenges remain in reaching undiagnosed populations and ensuring consistent care.
U.S. Cases on the Rise
The United States also reported an increase in TB cases in 2024, reaching the highest level in more than a dozen years. Preliminary data suggest that the majority of cases in the U.S. occur in individuals born outside the country. Public health officials continue to monitor trends closely, emphasizing the importance of early detection, particularly among high-risk populations.
Understanding Tuberculosis
TB is caused by the bacterium Mycobacterium tuberculosis, which primarily attacks the lungs but can affect other parts of the body. The disease spreads through airborne particles when an infected person coughs or sneezes. Although roughly a quarter of the global population carries TB bacteria, only a small fraction develop active disease. Without treatment, TB can be fatal, making it one of the leading causes of death worldwide.
Challenges in Funding and Global Response
The WHO compiles its TB reports annually, with the 2024 data encompassing 184 countries. Experts express concern over stagnating funding for TB prevention and treatment, particularly following recent budget reductions by the U.S. government and other major donors. Public health advocates warn that declining resources could reverse recent gains in global TB control.
Conclusion
Despite the increase in reported TB cases, the decline in deaths reflects progress in early detection and treatment programs. Strengthening global funding, expanding access to care, and sustaining screening initiatives remain critical to controlling the disease and preventing future outbreaks.
Related topics
